MARKET

VERA

VERA

Vera Therapeutics, Inc.
NASDAQ
30.03
-0.58
-1.89%
After Hours: 29.90 -0.13 -0.43% 19:33 11/10 EST
OPEN
30.20
PREV CLOSE
30.61
HIGH
31.07
LOW
29.80
VOLUME
1.85M
TURNOVER
--
52 WEEK HIGH
56.05
52 WEEK LOW
26.00
MARKET CAP
2.17B
P/E (TTM)
-5.0859
1D
5D
1M
3M
1Y
5Y
1D
Aurinia: Paying For Growth That Is Already Fading
Seeking Alpha · 15h ago
Weekly Report: what happened at VERA last week (1102-1106)?
Weekly Report · 1d ago
Bank of America Securities Remains a Buy on Vera Therapeutics (VERA)
TipRanks · 3d ago
Vera Therapeutics Price Target Cut to $29.00/Share From $34.00 by Wedbush
Dow Jones · 4d ago
Vera Therapeutics Is Maintained at Neutral by Wedbush
Dow Jones · 4d ago
Wedbush Maintains Neutral on Vera Therapeutics, Lowers Price Target to $29
Benzinga · 4d ago
Vera Therapeutics Is Maintained at Buy by Guggenheim
Dow Jones · 4d ago
Vera Therapeutics Price Target Cut to $66.00/Share From $76.00 by Guggenheim
Dow Jones · 4d ago
More
About VERA
Vera Therapeutics, Inc. is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B-cell Activating Factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), which stimulate B cells to produce autoantibodies contributing to certain autoimmune diseases, including IgAN, also known as Berger's disease, and lupus nephritis. In addition, it is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove medically useful. It is also engaged in developing MAU868, a monoclonal antibody designed to neutralize infection with BK virus (BKV), a polyomavirus that can have devastating consequences in certain settings such as kidney transplant. It retains all global developmental and commercial rights to atacicept and MAU868.

Webull offers Vera Therapeutics, Inc stock information, including NASDAQ: VERA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VERA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VERA stock methods without spending real money on the virtual paper trading platform.